The greenlight for Journavx (suzetrigine), which comes on the heels of a $7.4 billion opioid settlement, could spark momentum ...

FDA approves non-opioid pain reliever, suzetrigine, by Vertex Pharmaceuticals to mitigate risks of opioids and provide ...

Gibson called for more funds to be allocated for mobile units to care for drug users in the Bronx; Naloxone training for residents and caregivers; and an ...

After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...

The new drug type targets pathways in the peripheral nervous system before pain signals reach the brain, potentially lowering ...

Suzetrigine (Journavx) is the first new drug approved to treat acute pain in over 20 years and the first to be classified as ...

It's the first new pharmaceutical approach to treating pain in over 20 years, designed to eliminate risks of addiction and overdose associated with opioids.

Your Purdue ID card sometimes referred to as your PUID card or photo ID, proclaims you as a member of the Purdue community. It provides access to a variety of services on and off campus with a ...

See below for access to detailed information regarding 2023-24 Purdue tuition, rates and fees for undergraduate students, including summer, fall/spring and winter rate information as well as other ...

Gland Pharma Ltd., incorporated in the year 1978, is a Small Cap company (having a market cap of Rs 24,818.20 Crore) operating in Pharmaceuticals sector. Gland Pharma Ltd. key Products/Revenue ...